Mereo Biopharma Group PLC (NASDAQ:MREO)
| 0.8575 Delayed Data As of 3:58pm ET |  +0.1175 / +15.88%Today’s Change | 0.30 Today|||52-Week Range 1.85 | +14.33% Year-to-Date |
Latest MREO News | Press Releases
No recent news for Mereo Biopharma Group PLC.
Today’s Trading
| Previous close | 0.74 |
| Today’s open | 0.85 |
| Day’s range | 0.80 - 0.86 |
| Volume | 18,841 |
| Average volume (3 months) | 777,289 |
| Market cap | $105.0M |
Data as of 3:58pm ET, 03/21/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -11.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 3.72 |
| Price/Book | 0.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DTILPrecision BioScience... | +0.01 | +1.20% |
| VSTMVerastem Inc | -0.01 | -1.10% |
| PIRSPieris Pharmaceutica... | +0.12 | +9.50% |
| --Adocia SA | 0.00 | 0.00% |
Data as of 3:59pm ET, 03/21/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $50.1M |
| Annual profit (last year) | $17.5M |
| Net profit margin | 34.90% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
